澳门威斯人8040com-澳门威尼娱人网站
Home
Products
Pharmaceutical Products
Consumer Healthcare
R&D
R&D Focus Areas
Dosage Forms
Quality System
Partnership
Collaborations
Our Service
Service Scope
News
Company
What We Do
Mission
Values
History
Responsibility
Social Activity
Public Service
Environment
Careers
Life at CF
Meet Us
Opportunity
Contact
English
中文简体
News
Press Releases
2020-07-03
CF PharmTech, Inc. Closes a US $50M Series F Financing to Accelerate the Commercialization of its Inhalation Products.
